Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.
Journal: Bioinformatics (Oxford, England) 20100615
Title: Structures from powders: diflorasone diacetate.
Journal: Steroids 20090101
Title: German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).
Journal: Archives of dermatological research 20070601
Title: Maternal allergic contact dermatitis causes increased asthma risk in offspring.
Journal: Respiratory research 20070101
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis.
Journal: Experimental dermatology 20060401
Title: Cutaneous reactions to imatinib mesylate treated by topical steroid.
Journal: American journal of hematology 20050301
Title: Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.
Journal: Journal of burns and wounds 20050101
Title: TARC and RANTES, but not CTACK, are induced in two models of allergic contact dermatitis. Effects of cilomilast and diflorasone diacetate on T-cell-attracting chemokines.
Journal: The British journal of dermatology 20041001
Title: Class I topical corticosteroid use by psoriasis patients in an academic practice.
Journal: The Journal of dermatological treatment 20040701
Title: AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.
Journal: The Journal of pharmacy and pharmacology 20030801
Title: A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
Journal: Journal of cutaneous medicine and surgery 20020101
Title: A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
Journal: International journal of dermatology 20010701
Title: Elisabetta Maccaroni, et al. Structures from powders: diflorasone diacetate. Steroids. 2009 Jan;74(1):102-11.
